Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$19.4K Buy
+299
New +$13.5K ﹤0.01% 1521
2026
Q1
– Sell
-1
Closed -$19 – 2544
2025
Q4
$19 Buy
+1
New +$17 ﹤0.01% 2525
2025
Q2
– Sell
-466
Closed -$8.27K – 2469
2025
Q1
$8.27K Hold
466
– – ﹤0.01% 1976
2024
Q4
$10K Buy
466
+436
+1,453% +$10.6K ﹤0.01% 1869
2024
Q3
$466 Buy
30
+17
+131% +$423 ﹤0.01% 2801
2024
Q2
$138 Buy
+13
New +$157 ﹤0.01% 2673
2024
Q1
– Sell
-52
Closed – – 2260
2023
Q4
$0 Buy
+52
New +$426 ﹤0.01% 2508
2023
Q1
– Sell
-11
Closed – – 2334
2022
Q4
$0 Buy
+11
New +$163 ﹤0.01% 2248

Other funds holding CDNA

Blue Trust's CDNA Position: Q3 2026 in Review

Blue Trust opened a new position in CareDx (CDNA) in Q3 2026: 299 shares worth $19.4K. The stake represents ﹤0.01% of the portfolio and ranks #1521 among its holdings. This is a return to the name: Blue Trust previously reported a position in CDNA as recently as Q4 2025.

Blue Trust first reported a position in CDNA in Q4 2022 and has held it in 8 quarters since. 245 funds tracked by Wall St. Rank hold CDNA as of Q3 2026.

  • Blue Trust held 299 shares of CareDx worth $19.4K as of Q3 2026.
  • CareDx was a new Blue Trust position in Q3 2026.
  • CareDx made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #1521 holding.
  • Blue Trust first reported a position in CareDx in Q4 2022 and has held it in 8 quarters since.
  • 245 funds tracked by Wall St. Rank held CareDx as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.